These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 23642919

  • 1. Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon.
    Thomas SD, McDonald RR, Varcoe RL.
    J Vasc Surg; 2014 Feb; 59(2):520-3. PubMed ID: 23642919
    [Abstract] [Full Text] [Related]

  • 2. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M, Torsello GB, Schönefeld E, Imm B, Osada N, Stahlhoff S.
    J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
    [Abstract] [Full Text] [Related]

  • 3. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D, Schmidt A, Zeller T, Müller-Hülsbeck S, Sixt S, Schröder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K.
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the Biodegradable Igaki-Tamai Scaffold After Drug-Eluting Balloon Treatment of De Novo Superficial Femoral Artery Lesions: The GAIA-DEB Study.
    Werner M, Schmidt A, Scheinert S, Banning-Eichenseer U, Ulrich M, Bausback Y, Steiner S, Scheinert D.
    J Endovasc Ther; 2016 Feb; 23(1):92-7. PubMed ID: 26620399
    [Abstract] [Full Text] [Related]

  • 5. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain.
    Zeller T, Brodmann M, Micari A, Keirse K, Peeters P, Tepe G, Scheinert D, Jaff MR, Rocha-Singh KJ, Li P, Schmahl R, Ansel GM, IN.PACT Global Study Investigators.
    Circ Cardiovasc Interv; 2019 Jan; 12(1):e007730. PubMed ID: 30630355
    [No Abstract] [Full Text] [Related]

  • 6. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry.
    Micari A, Cioppa A, Vadalà G, Castriota F, Liso A, Marchese A, Grattoni C, Pantaleo P, Cremonesi A, Rubino P, Biamino G.
    JACC Cardiovasc Interv; 2013 Mar; 6(3):282-9. PubMed ID: 23517840
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease.
    Kuo TT, Chen PL, Huang CY, Lee CY, Shih CC, Chen IM.
    J Vasc Surg; 2019 Jan; 69(1):141-147. PubMed ID: 30104098
    [Abstract] [Full Text] [Related]

  • 9. Missing the Forest for the Trees?: Drug-Eluting Balloon Treatment for Infrapopliteal Disease.
    Tsai TT.
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1623-5. PubMed ID: 26493254
    [No Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness analysis of paclitaxel-coated balloons for endovascular therapy of femoropopliteal arterial obstructions.
    Diehm N, Schneider H.
    J Endovasc Ther; 2013 Dec; 20(6):819-25. PubMed ID: 24325699
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of Drug-Eluting Balloon and Standard Balloon Angioplasty for Infrapopliteal Arterial Diseases in Diabetic Patients.
    Oz II, Serifoglu I, Bilici M, Altinbas NK, Oz EB, Akduman EI.
    Vasc Endovascular Surg; 2016 Nov; 50(8):534-540. PubMed ID: 28081691
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date.
    Barkat M, Torella F, Antoniou GA.
    Vasc Health Risk Manag; 2016 Nov; 12():199-208. PubMed ID: 27274265
    [Abstract] [Full Text] [Related]

  • 16. Kounis Syndrome after Angioplasty of the Superficial Femoral Artery with Paclitaxel-Coated Balloon.
    Narroway HG, Katib N, Gomes ML, Varcoe RL, Thomas SD.
    Ann Vasc Surg; 2020 Nov; 69():450.e17-450.e22. PubMed ID: 32561243
    [Abstract] [Full Text] [Related]

  • 17. Prime time for drug eluting balloons in SFA interventions?
    Brodmann M.
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):461-4. PubMed ID: 24941235
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Drug-coated balloons are replacing the need for nitinol stents in the superficial femoral artery.
    Kitrou P, Karnabatidis D, Katsanos K.
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):569-77. PubMed ID: 27128105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.